NRTX-1001
Neurona Therapeutics
[]
neurona therapeutics presents updated data from the nrtx-1001 cell therapy trial in adults with drug-resistant focal epilepsy at american academy of neurology (aan) 2023 annual meeting 
We provide a balanced view on small cap biotech equities.